Article Information
History
- October 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alasdair Taylor, PhD1,
- Moneeza K Siddiqui, PhD1,
- Philip Ambery, MBChB2,
- Javier Armisen, PhD3,
- Benjamin G. Challis, PhD5,
- Carolina Haefliger, MD4,
- Ewan R. Pearson, PhD1,
- Alex S.F. Doney, PhD1,
- John F. Dillon, MD6 and
- Colin N.A. Palmer, PhD1,*
- 1Population Health and Genomics, University of Dundee, Dundee, UK
- 2Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
- 3Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 4Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 5Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
- 6Molecular and Clinical Medicine, University of Dundee, Dundee, UK
- ↵*Corresponding Author Details
Professor Colin NA Palmer PhD FRSB FRSE, Associate Dean for Research and Chair of Pharmacogenomics, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK, Telephone Number (Office): +44 (0)1382 383155, Email: c.n.a.palmer{at}dundee.ac.uk
Contributors
AT, MKS, CNAP and JFD contributed to the study design, data collection, analysis, interpretation and drafting and critical revision of the manuscript.
PA, BC, CH and JA contributed to the data analysis, interpretation, drafting and critical revision of the manuscript.
ASFD and ERP contributed to data collection and critical revision of the manuscript.
All authors participated in the critical revision and final approval of this manuscript.
Posted October 20, 2021.
